Home » Biotechnology » Europe Single-Use Bio-Processing Systems Market

Europe Single-Use Bio-Processing Systems Market

Europe Single-Use Bio-Processing Systems Market By Type (Single-Use Bioreactors, Single-Use Mixers, Single-Use Bags, Single-Use Connectors, Others); By Application (Research & Development, Manufacturing, Process Development, Commercial Production, Others); By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, Contract Manufacturing Organizations (CMOs), Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Europe Single-Use Bio-Processing Systems Market Size 2024	USD 4,561.95 million
Europe Single-Use Bio-Processing Systems Market, CGR	15.40%
Europe Single-Use Bio-Processing Systems Market Size 2032	USD 14,352.42 million

Market Overview

Europe Single-Use Bio-Processing Systems market size was valued at USD 4,561.95 million in 2024 and is anticipated to reach USD 14,352.42 million by 2032, at a CAGR of 15.40% during the forecast period (2024-2032).

The Europe Single-Use Bio-Processing Systems market is driven by several key factors, including the growing demand for biopharmaceuticals, advancements in biotechnology, and the rising need for cost-effective, flexible, and efficient manufacturing processes. Single-use technologies offer significant advantages over traditional stainless-steel systems, such as reduced downtime, lower contamination risks, and shorter production cycles. Additionally, the increasing preference for personalized medicine, coupled with regulatory support for biopharmaceutical innovation, is fueling market growth. Technological advancements in materials and design are enhancing the performance and reliability of these systems, making them more attractive to biomanufacturers. Furthermore, the shift toward continuous bioprocessing and the expansion of biomanufacturing capacities in Europe are expected to accelerate market expansion. These trends underscore the growing importance of single-use bio-processing solutions in meeting the demands of modern biopharmaceutical production.

Geographically, the Europe Single-Use Bio-Processing Systems market is dominated by key regions such as the United Kingdom, Germany, France, and Switzerland, which are home to leading pharmaceutical and biomanufacturing hubs. These countries are at the forefront of adopting innovative bio-processing technologies, driven by strong research and development activities, regulatory support, and the increasing demand for biologics. The rest of Europe, including Spain, Italy, and the Nordics, also shows significant growth potential, with expanding biomanufacturing facilities and rising demand for efficient production methods. Key players in the market include Sartorius AG, Merck KGaA, Eppendorf AG, Lonza Group AG, and Stedim Biotech, among others. These companies are instrumental in advancing single-use bio-processing systems through product innovations and strategic partnerships. Their continuous efforts in expanding product portfolios and improving system integration are driving market growth and shaping the future of biopharmaceutical production in Europe.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The Europe Single-Use Bio-Processing Systems market was valued at USD 4,561.95 million in 2024 and is expected to reach USD 14,352.42 million by 2032, growing at a CAGR of 15.40% during the forecast period (2024-2032).

The global single-use bio-processing systems market was valued at USD 17,326.05 million in 2024 and is projected to reach USD 57,663.39 million by 2032, growing at a CAGR of 16.22% from 2024 to 2032.
The increasing demand for biologics and personalized medicine is driving market growth.

The adoption of continuous bioprocessing and single-use technologies is expanding across Europe.
Technological advancements, including automation and smart sensors, are enhancing system efficiency and scalability.
Key players in the market include Sartorius AG, Merck KGaA, Eppendorf AG, and Lonza Group AG.
High initial investment costs and limited standardization are significant market restraints.
The UK, Germany, France, and Switzerland are key regions contributing to the market, with strong biopharmaceutical industries and increasing biomanufacturing capacities.

Report Scope

This report segments the Europe Single-Use Bio-Processing Systems Market as follows:

Europe Single-Use Bio-Processing Systems Market

Market Drivers

Growing Demand for Biopharmaceuticals

The increasing demand for biopharmaceutical products continues to drive the Europe Single-Use Bio-Processing Systems market. Industry reports highlight that biopharmaceutical manufacturers are increasingly adopting single-use technologies to streamline production and enhance efficiency. For instance, regulatory agencies and industry surveys indicate that the adoption of single-use systems has significantly improved the speed and flexibility of biologic drug production, particularly for monoclonal antibodies and gene therapies. Additionally, the shift towards personalized medicine has led to a rise in small-scale, patient-specific treatments, further reinforcing the need for adaptable and cost-effective production technologies

Cost-Effectiveness and Operational Efficiency

Single-use bio-processing systems provide a more cost-effective and operationally efficient alternative to traditional stainless-steel systems. Unlike stainless-steel systems, which require extensive cleaning, sterilization, and maintenance, single-use systems are designed to be used for a single production cycle and then discarded, significantly reducing operational costs. The elimination of cleaning and sterilization processes also reduces the risk of contamination between production batches, improving the overall safety and quality of the final product. These systems also shorten production timelines, enabling faster time-to-market for biopharmaceuticals, which is crucial in today’s competitive industry landscape. The reduced upfront investment and lower operational costs associated with single-use systems make them an attractive option for both large pharmaceutical companies and smaller biotechnology firms.

Technological Advancements and Innovation

Technological advancements in single-use bio-processing systems are playing a pivotal role in market growth. Reports from industry experts highlight innovations such as advanced filtration, enhanced sensors, and improved compatibility with different bioreactor platforms. For instance, research institutions and biopharmaceutical companies have developed next-generation single-use technologies with more robust and temperature-resistant materials, ensuring they can handle complex production processes. Continuous improvements in system performance, including increased scalability and better integration with existing infrastructure, are making single-use systems more appealing to a broader range of manufacturers

Regulatory Support and Biomanufacturing Growth

Regulatory support for the adoption of single-use bio-processing systems is another key factor driving market growth in Europe. Regulatory bodies, such as the European Medicines Agency (EMA), have increasingly recognized the advantages of single-use systems in maintaining high production standards while reducing risks associated with contamination and cross-contamination. As the demand for biologics continues to rise, regulatory frameworks have adapted to accommodate the use of these innovative technologies in both clinical and commercial-scale production. Additionally, the expansion of biomanufacturing capacities in Europe, particularly in countries like Germany, Switzerland, and the United Kingdom, is further stimulating market growth. Investments in biomanufacturing facilities and the shift towards continuous bioprocessing techniques are creating more opportunities for single-use bio-processing solutions, as they align with the industry’s evolving needs for greater flexibility, scalability, and efficiency.

Market Trends

Shift Toward Continuous Bioprocessing

A significant trend in the Europe Single-Use Bio-Processing Systems market is the growing adoption of continuous bioprocessing. Unlike traditional batch processes, continuous bioprocessing allows for uninterrupted production, increasing efficiency, and reducing production time. Single-use systems are ideal for continuous processes due to their flexibility, scalability, and minimal downtime between batches. For instance, surveys conducted by biomanufacturing associations indicate that continuous bioprocessing has led to improved scalability and cost savings for biologics production. As biopharmaceutical manufacturers seek to streamline production and reduce costs, continuous bioprocessing has become an increasingly attractive option. This shift aligns with industry efforts to enhance the overall productivity of biomanufacturing operations.

Expansion of Biomanufacturing Facilities in Europe

The expansion of biomanufacturing facilities across Europe is another key trend driving the growth of single-use bio-processing systems. As demand for biologics and vaccines increases, many pharmaceutical companies are investing in new, state-of-the-art biomanufacturing plants equipped with advanced single-use technologies. For instance, surveys conducted in Switzerland, Germany, and the UK highlight the increasing adoption of single-use systems in newly established production hubs. The ability to easily scale up or down using single-use systems allows manufacturers to adapt to the fluctuating demands of biologic production. This trend is especially visible in countries with a high concentration of biopharmaceutical production, such as Switzerland, Germany, and the UK, where the growth of new manufacturing hubs is driving the adoption of these systems.

Increased Use in Personalized Medicine

Another prominent trend is the growing role of single-use bio-processing systems in personalized medicine. The shift toward personalized treatments, which require the production of biologic drugs tailored to individual patients, has led to increased demand for flexible, scalable production technologies. Single-use systems are highly suitable for small-batch, patient-specific production, as they can be easily reconfigured and deployed for various therapeutic applications. These systems enable the production of complex biologics, such as gene therapies, cell therapies, and tissue-engineered products, which are central to the personalized medicine trend. The ability to efficiently handle small-scale and customized manufacturing is fueling the widespread adoption of single-use technologies in this rapidly growing segment of the biopharmaceutical market.

Advancements in Materials and Automation

Technological innovation is a key trend driving the Europe Single-Use Bio-Processing Systems market. Recent advancements in materials, such as improved biocompatible plastics and enhanced sensors, are enhancing the performance and reliability of single-use systems. These materials allow for higher resistance to chemical interactions, temperature variations, and other harsh conditions encountered during bioprocessing. In addition to material innovations, the integration of automation technologies is also gaining traction. Automated systems improve the precision and consistency of bio-processing operations, further reducing the risk of human error and contamination. The increased incorporation of smart technologies and sensors for real-time monitoring and control is also transforming the way single-use systems are utilized, optimizing production processes and ensuring higher quality standards.

Market Challenges Analysis

High Initial Investment and Operating Costs

One of the key challenges facing the Europe Single-Use Bio-Processing Systems market is the high initial investment and operating costs associated with adopting these technologies. While single-use systems offer long-term cost savings by reducing maintenance and cleaning requirements, the upfront capital required to purchase and integrate these systems can be significant, especially for smaller or mid-sized biopharmaceutical companies. Additionally, single-use consumables such as bags, filters, and tubing, which need to be replaced after each production cycle, contribute to ongoing operational costs. These costs can accumulate quickly, particularly for large-scale production, making it difficult for some companies to justify the shift from traditional stainless-steel systems. Despite the cost benefits in terms of time and operational efficiency, financial considerations remain a major barrier for many manufacturers.

Limited Standardization and Compatibility Issues

Another challenge is the lack of standardization and potential compatibility issues between different single-use systems. Industry research suggests that variations in design, material specifications, and automation integration across manufacturers can complicate scalability and system integration. For instance, biopharmaceutical sector highlight concerns regarding equipment interoperability, which can impact production efficiency and introduce contamination risks. As the industry moves toward more complex biomanufacturing processes, reports from regulatory bodies emphasize the growing need for higher levels of system compatibility and standardization to ensure seamless operations. These compatibility issues can slow down the adoption of single-use technologies, as companies may be hesitant to invest in solutions that are not universally applicable across different stages of production or types of biologics.

Market Opportunities

The Europe Single-Use Bio-Processing Systems market presents significant opportunities driven by the growing demand for biologics, personalized medicine, and the increasing shift towards more efficient and flexible manufacturing processes. The rising prevalence of chronic diseases and the continuous development of innovative biopharmaceuticals, such as gene and cell therapies, offer substantial growth prospects for single-use systems. These therapies often require smaller, more flexible production runs, a need perfectly aligned with the capabilities of single-use technologies. Additionally, as biopharmaceutical companies increasingly focus on reducing production costs and time-to-market, the ability of single-use systems to provide cost-effective, scalable, and quicker production cycles positions them as an attractive solution. The expansion of personalized medicine, which requires tailored biopharmaceutical treatments, further drives the demand for these adaptable production methods, creating ample opportunities for single-use bio-processing system providers.

The market also offers opportunities for further innovation and technological advancement. As biomanufacturers continue to seek higher levels of efficiency, advancements in materials, automation, and data integration present new avenues for single-use systems. The development of more robust materials and smarter systems with integrated sensors and real-time monitoring capabilities could enhance the reliability and performance of single-use bio-processing systems, making them even more attractive to manufacturers. Moreover, the ongoing trend of biomanufacturing facility expansion in Europe, particularly in regions such as Germany, Switzerland, and the UK, provides a favorable environment for the adoption of single-use systems. These developments open up new business prospects for system manufacturers, as well as suppliers of consumables, spare parts, and maintenance services. As the market continues to grow and evolve, opportunities for industry players to provide innovative, tailored solutions that meet the increasing demands of biopharmaceutical production will continue to rise.

Market Segmentation Analysis:

By Type:

The Europe Single-Use Bio-Processing Systems market is segmented into various types, each contributing to the growing adoption of single-use technologies. Single-use bioreactors are one of the largest segments, offering advantages such as flexibility, scalability, and reduced risk of contamination in the production of biologics. These bioreactors are particularly favored for their ability to facilitate small-scale, high-quality production. Single-use mixers are another critical component, enabling efficient and contamination-free mixing of fluids in biopharmaceutical manufacturing. These mixers provide precise control over process parameters, ensuring consistent quality in biologic production. Single-use bags are widely used in cell culture, storage, and transport applications, offering excellent compatibility with other single-use components. The single-use connectors segment, including valves, tubing, and fittings, plays a vital role in ensuring seamless and safe connections during production. Other segments, such as single-use filters and sensors, also contribute to the overall market, with increasing demand for integrated solutions that enhance process control and monitoring.

By Application:

The Europe Single-Use Bio-Processing Systems market is also segmented based on application, with each segment experiencing significant growth due to the increasing adoption of single-use technologies. Research & Development (R&D) is a key application, as single-use systems provide a cost-effective and scalable solution for early-stage drug development. The flexibility and rapid turnaround time offered by single-use systems make them ideal for small-scale R&D activities. In manufacturing, single-use systems are used to streamline large-scale biologics production, reducing the need for expensive infrastructure investments. The process development segment focuses on optimizing production processes and scaling them up for commercialization, with single-use systems offering a high degree of customization and adaptability. Commercial production of biologics is another growing application, as single-use systems are increasingly being employed to meet the demand for flexible, efficient, and contaminant-free production. Finally, other applications such as vaccine production and gene therapy manufacturing are gaining traction, further expanding the scope of single-use systems in biomanufacturing.

Segments:

Based on Type:

Single-Use Bioreactors
Single-Use Mixers
Single-Use Bags
Single-Use Connectors
Others

Based on Application:

Research & Development
Manufacturing
Process Development
Commercial Production
Others

Based on End- User:

Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Contract Manufacturing Organizations (CMOs)
Others

Based on the Geography:

UK
France
Germany
Italy
Spain
Russia
Belgium
Netherlands
Austria
Sweden
Poland
Denmark
Switzerland
Rest of Europe

Regional Analysis

United Kingdom

The United Kingdom holds a significant share of the Europe Single-Use Bio-Processing Systems market, accounting for approximately 24% of the regional market. The UK’s strong pharmaceutical and biotechnology sector, coupled with its advanced research and development capabilities, makes it a key player in the adoption of single-use technologies. The country’s robust regulatory framework and favorable government policies promoting biopharmaceutical innovation further enhance the demand for flexible and cost-effective bio-processing systems. Additionally, the presence of several leading biomanufacturers and the growth of biomanufacturing facilities in the UK are expected to contribute to continued market expansion in this region.

Germany

Germany is another major player in the European market, contributing around 22% of the total market share. As one of Europe’s largest economies and a global leader in pharmaceutical production, Germany offers a strong foundation for the growth of single-use bio-processing systems. The country is home to numerous biopharmaceutical companies, contract manufacturing organizations, and cutting-edge research institutions. Furthermore, Germany’s emphasis on sustainable and efficient production methods has accelerated the adoption of single-use systems in the biomanufacturing sector. The ongoing expansion of biopharmaceutical manufacturing capacities and increasing demand for biologics contribute to Germany’s prominent market position.

France and Switzerland

France and Switzerland together hold approximately 18% of the market share. France’s established pharmaceutical industry, supported by research hubs and a favorable regulatory environment, continues to drive the adoption of single-use systems, particularly in the production of biologics and vaccines. Switzerland, known for its strong pharmaceutical and biotech industries, plays a crucial role in the market as well. The presence of major global players in Switzerland, coupled with the country’s high standards for biomanufacturing and its support for innovation in life sciences, further drives the demand for advanced bio-processing technologies, including single-use systems. Both countries are expected to experience steady growth as biomanufacturers increasingly rely on these flexible and efficient production solutions.

Rest of Europe

The remaining countries in Europe, which include Spain, Italy, Russia, Belgium, Netherlands, Austria, Sweden, Poland, Denmark, and others, account for approximately 36% of the market share. Although individual countries in this category may have smaller shares compared to the UK, Germany, and France, the combined demand for single-use bio-processing systems is substantial. Spain and Italy are seeing increased investments in biomanufacturing facilities and are gradually adopting single-use technologies to enhance the efficiency of their biopharmaceutical production processes. Meanwhile, countries like Russia and Poland are expanding their pharmaceutical industries, which is fostering increased demand for flexible production systems. Overall, the rest of Europe offers substantial growth opportunities as biomanufacturers across these countries continue to adopt single-use bio-processing solutions to meet evolving market demands.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Sartorius AG
Merck KGaA
Eppendorf AG
Celltainer Biotech BV
Lonza Group AG
Getinge AB
RoSS GmbH
Elveflow
Finesse Solutions
Stedim Biotech

Competitive Analysis

The Europe Single-Use Bio-Processing Systems market is highly competitive, with several key players leading the industry through innovation and strategic partnerships. Sartorius AG, Merck KGaA, Eppendorf AG, Celltainer Biotech BV, Lonza Group AG, Getinge AB, RoSS GmbH, Elveflow, Finesse Solutions, and Stedim Biotech are at the forefront, providing advanced technologies for biopharmaceutical production. Competitive strategies include significant investments in research and development to enhance system performance, improve scalability, and integrate automation for more efficient production processes. Many companies are forming strategic partnerships and collaborations to leverage complementary strengths and broaden their market reach. With an increasing focus on personalized medicine and biologic therapies, firms are working to create flexible and scalable solutions that can cater to small-batch production as well as large-scale commercial manufacturing. Moreover, these players are actively pursuing expansions into emerging markets, further solidifying their market positions. In addition, the market is witnessing an ongoing trend toward continuous bioprocessing and automation, which is fueling demand for more integrated and sophisticated bio-processing systems. Companies are focusing on providing high-quality, cost-effective, and innovative solutions to meet the evolving needs of biomanufacturers across Europe, positioning themselves as key contributors to the region’s expanding biopharmaceutical industry.

Recent Developments

In April 2025, Thermo Fisher Scientific launched the 5L DynaDrive Single-Use Bioreactor, a bench-scale system designed for seamless scalability from 1 to 5,000 liters. This new bioreactor offers a 27% productivity increase over glass bioreactors, enhanced sustainability with biobased films, and consistent performance across different scales, supporting both large and small biopharma manufacturers. The DynaDrive S.U.B. supports robust production across scales and has the flexibility to accommodate a variety of cell lines and processing modalities.
In April 2025, Sartorius Stedim Biotech entered a strategic partnership with Tulip Interfaces to drive digital transformation in single-use bioprocessing. The collaboration introduced Biobrain® Operate powered by Tulip, a suite of digital manufacturing applications that integrate with Sartorius equipment to reduce process variability, digitize operations, and ensure regulatory compliance. This partnership aims to advance paperless manufacturing and optimize resource efficiency in bioprocessing.
In March 2025, Corning introduced new technologies to support advanced therapy applications, including the Ascent™ Fixed Bed Reactor (FBR) and expanded cell expansion platforms like HYPERStack®, HYPERFlask®, and CellSTACK®. These platforms feature closed systems and automation to reduce contamination risk and enhance scalability for bioprocess applications.
In April 2023, Merck KGaA launched the Ultimus® Single-Use Process Container Film, featuring ten times greater abrasion resistance than other films, improved durability, and leak resistance for single-use assemblies. The technology is now available in Mobius® 3D process containers, enhancing operational efficiency and cell growth performance.

Market Concentration & Characteristics

The Europe Single-Use Bio-Processing Systems market exhibits moderate to high concentration, with a few dominant players leading the industry. These companies hold a significant share of the market, driving innovation and setting industry standards through continuous product development and strategic partnerships. The market is characterized by a combination of large multinational corporations and smaller, specialized firms, each contributing to the growth of the sector through advanced technologies and customized solutions. Leading players typically focus on expanding their product portfolios to include a wide range of single-use components such as bioreactors, mixers, bags, and connectors, addressing the diverse needs of the biopharmaceutical manufacturing process. The competitive landscape is further shaped by factors such as technological advancements, regulatory support, and the increasing demand for flexible, scalable, and cost-effective manufacturing solutions. As the biopharmaceutical sector grows, the market is expected to become increasingly competitive, with more players entering the space to capitalize on rising demand

Report Coverage

The research report offers an in-depth analysis based on Type, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The demand for single-use bio-processing systems will continue to rise due to the growing biologics and personalized medicine sectors.
Continuous bioprocessing is expected to gain more traction, improving production efficiency and reducing downtime.
Technological advancements in automation and smart sensors will enhance the flexibility and scalability of bio-processing systems.
The expansion of biomanufacturing facilities in Europe will drive the adoption of single-use systems for both small-scale and commercial production.
Companies will focus on reducing the environmental impact of single-use technologies by improving material sustainability and recyclability.
The trend towards modular and integrated bio-processing systems will provide greater adaptability in production environments.
Increased investments in research and development will lead to more sophisticated and high-performing single-use solutions.
The growing emphasis on cost reduction and faster time-to-market will encourage more biopharmaceutical companies to adopt single-use technologies.
The rising demand for cell and gene therapies will further accelerate the use of single-use systems in specialized therapeutic applications.
Strategic collaborations and partnerships between technology providers and biopharmaceutical manufacturers will drive market growth and innovation.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Single-Use Bio-Processing Systems Market Snapshot 21

2.1.1. Europe Single-Use Bio-Processing Systems Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Growing Adoption of Disposable Technologies in Biopharmaceutical Manufacturing 25

4.2.2. Increasing Demand for Cost-Effective and Scalable Bioprocessing Solutions 26

4.3. Market Restraints 27

4.3.1. Concerns Related to Leachables and Extractables in Single-Use Systems 27

4.4. Market Opportunities 28

4.4.1. Advancements in Bioprocessing Technology Driving Innovation in Single-Use Systems 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by Europe 31

5.1.1. Europe Single-Use Bio-Processing Systems Market Import Volume/Revenue, By Europe, 2018 – 2023 31

5.2. Export Analysis by Europe 32

5.2.1. Europe Single-Use Bio-Processing Systems Market Export Volume/Revenue, By Europe, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by Europe 33

6.1.1. Europe Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By Europe, 2018 – 2023 33

6.2. Supply Analysis by Europe 34

6.2.1. Europe Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By Europe, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by Europe 35

7.1.1. Europe Single-Use Bio-Processing Systems Market Production Volume/Revenue, By Europe, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. Europe Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

8.1.2. Europe Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. Europe Single-Use Bio-Processing Systems Market: Company Market Share, by Volume, 2023 40

11.2.2. Europe Single-Use Bio-Processing Systems Market: Company Market Share, by Revenue, 2023 41

11.2.3. Europe Single-Use Bio-Processing Systems Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. Europe Single-Use Bio-Processing Systems Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. Europe Single-Use Bio-Processing Systems Market Company Volume Market Share, 2023 43

11.4. Europe Single-Use Bio-Processing Systems Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

Europe Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Single-Use Bio-Processing Systems Market Overview, by Type Segment 49

13.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Single-Use Bioreactors 53

13.3. Single-Use Mixers 54

13.4. Single-Use Bags 55

13.5. Single-Use Connectors 56

13.6. Others 57

CHAPTER NO. 14 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY APPLICATION SEGMENT ANALYSIS 58

14.1. Single-Use Bio-Processing Systems Market Overview, by Application Segment 58

14.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

14.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Application 60

14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 60

14.1.4. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

14.2. Research & Development 62

14.3. Manufacturing 63

14.4. Process Development 64

14.5. Commercial Production 65

14.6. Others 66

CHAPTER NO. 15 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY END-USER SEGMENT ANALYSIS 67

15.1. Single-Use Bio-Processing Systems Market Overview, by End-user Segment 67

15.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

15.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By End-user 69

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 69

15.1.4. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

15.2. Pharmaceutical & Biotechnology Companies 71

15.3. Contract Research Organizations (CROs) 72

15.4. Academic & Research Institutes 73

15.5. Contract Manufacturing Organizations (CMOs) 74

15.6. Others 75

CHAPTER NO. 16 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – EUROPE ANALYSIS 76

16.1. Type 76

16.1.1. Europe Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

16.2. Europe Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

16.3. Application 77

16.3.1. Europe Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

16.3.2. Europe Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

16.4. End-user 78

16.4.1. Europe Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

16.4.2. Europe Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

16.5. UK 79

16.6. France 79

16.7. Germany 79

16.8. Italy 79

16.9. Spain 79

16.10. Russia 79

16.11. Belgium 79

16.12. Netherland 79

16.13. Austria 79

16.14. Sweden 79

16.15. Poland 79

16.16. Denmark 79

16.17. Switzerland 79

16.18. Rest of Europe 79

CHAPTER NO. 17 : COMPANY PROFILES 80

17.1. Sartorius AG 80

17.1.1. Company Overview 80

17.1.2. Product Portfolio 80

17.1.3. Swot Analysis 80

17.1.4. Business Strategy 81

17.1.5. Financial Overview 81

17.2. Merck KGaA 82

17.3. Eppendorf AG 82

17.4. Celltainer Biotech BV 82

17.5. Lonza Group AG 82

17.6. Getinge AB 82

17.7. RoSS GmbH 82

17.8. Elveflow 82

17.9. Finesse Solutions 82

17.10. Stedim Biotech 82

List of Figures

FIG NO. 1. Europe Single-Use Bio-Processing Systems Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Europe Single-Use Bio-Processing Systems Market 29

FIG NO. 3. Europe Single-Use Bio-Processing Systems Market Import Volume/Revenue, By Europe, 2018 – 2023 31

FIG NO. 4. Europe Single-Use Bio-Processing Systems Market Export Volume/Revenue, By Europe, 2018 – 2023 32

FIG NO. 5. Europe Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By Europe, 2018 – 2023 33

FIG NO. 6. Europe Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By Europe, 2018 – 2023 34

FIG NO. 7. Europe Single-Use Bio-Processing Systems Market Production Volume/Revenue, By Europe, 2018 – 2023 35

FIG NO. 8. Europe Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for Europe Single-Use Bio-Processing Systems Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Single-Use Bio-Processing Systems Market – Company Volume Market Share, 2023 43

FIG NO. 18. Single-Use Bio-Processing Systems Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Europe Single-Use Bio-Processing Systems Market for Single-Use Bioreactors, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Europe Single-Use Bio-Processing Systems Market for Single-Use Mixers, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Europe Single-Use Bio-Processing Systems Market for Single-Use Bags, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. Europe Single-Use Bio-Processing Systems Market for Single-Use Connectors, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. Europe Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Application 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 60

FIG NO. 31. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

FIG NO. 32. Europe Single-Use Bio-Processing Systems Market for Research & Development, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Europe Single-Use Bio-Processing Systems Market for Manufacturing, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. Europe Single-Use Bio-Processing Systems Market for Process Development, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. Europe Single-Use Bio-Processing Systems Market for Commercial Production, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. Europe Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. Europe Single-Use Bio-Processing Systems Market for Pharmaceutical & Biotechnology Companies, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. Europe Single-Use Bio-Processing Systems Market for Contract Research Organizations (CROs), Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. Europe Single-Use Bio-Processing Systems Market for Academic & Research Institutes, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. Europe Single-Use Bio-Processing Systems Market for Contract Manufacturing Organizations (CMOs), Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. Europe Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 75

List of Tables

TABLE NO. 1. : Europe Single-Use Bio-Processing Systems Market: Snapshot 21

TABLE NO. 2. : Drivers for the Single-Use Bio-Processing Systems Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Single-Use Bio-Processing Systems Market: Impact Analysis 27

TABLE NO. 4. : Europe Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : Europe Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

TABLE NO. 7. : Europe Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

TABLE NO. 8. : Europe Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

TABLE NO. 9. : Europe Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

TABLE NO. 10. : Europe Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

TABLE NO. 11. : Europe Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

Frequently Asked Questions

What is the current size of the Europe Single-Use Bio-Processing Systems?

The market was valued at USD 4,561.95 million in 2024 and is projected to reach USD 14,352.42 million by 2032.

What factors are driving the growth of the Europe Single-Use Bio-Processing Systems?

Rising demand for biologics, cost-effective manufacturing, and advancements in biotechnology are key growth drivers.

What are some challenges faced by the Europe Single-Use Bio-Processing Systems?

High initial investment and limited standardization are major challenges impacting adoption

Who are the major players in the Europe Single-Use Bio-Processing Systems?

Key players include Sartorius AG, Merck KGaA, Eppendorf AG, and Lonza Group AG.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Let us help you

MIKE, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –